BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4079454)

  • 1. Tyrosine protein kinases and their substrates in human leukemia cells.
    Wickremasinghe RG; Piga A; Mire AR; Taheri MR; Yaxley JC; Hoffbrand AV
    Leuk Res; 1985; 9(12):1443-50. PubMed ID: 4079454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine protein kinase activity in normal and leukaemic human blood cells.
    Punt CJ; Rijksen G; Vlug AM; Dekker AW; Staal GE
    Br J Haematol; 1989 Sep; 73(1):51-6. PubMed ID: 2803978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias.
    Lower EE; Franco RS; Martelo OJ
    Am J Med Sci; 1992 Jun; 303(6):387-91. PubMed ID: 1605167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher tyrosine protein kinase activity in resting lymphocytes than in proliferating normal or leukaemic blood cells.
    Piga A; Taheri MR; Yaxley JC; Wickremasinghe RG; Hoffbrand AV
    Biochem Biophys Res Commun; 1984 Nov; 124(3):766-73. PubMed ID: 6542362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
    Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of tyrosine protein kinase substrates in fresh leukemia cells and normal blood cells using an immunoblotting technique.
    Evans JP; Wickremasinghe RG; Hoffbrand AV
    Leukemia; 1987 Nov; 1(11):782-5. PubMed ID: 3316858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
    Durocher Y; Chapdelaine A; Chevalier S
    Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of three major protein kinase C isozymes in various types of human leukemic cells.
    Komada F; Nishikawa M; Uemura Y; Morita K; Hidaka H; Shirakawa S
    Cancer Res; 1991 Aug; 51(16):4271-8. PubMed ID: 1868447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of specific tyrosine phosphorylation with stages of B-cell differentiation in human lymphoid leukemias.
    Kuratsune H; Owada K; Machii T; Nishimori Y; Ueda E; Tokumine Y; Tagawa S; Taniguchi N; Fujio H; Kitani T
    Biochem Biophys Res Commun; 1985 Dec; 133(2):598-607. PubMed ID: 3878711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytohemagglutinin-induced changes in tyrosine protein kinase and its endogenous substrates in human lymphocytes.
    Piga A; Wickremasinghe RG; Taheri MR; Yaxley JC; Hoffbrand AV
    Exp Cell Res; 1985 Jul; 159(1):103-12. PubMed ID: 4040863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA nucleotidylexotransferase of normal persons and leukemic patients.
    Yasmineh WG; Smith BM; Bloomfield CD
    Clin Chem; 1980 Jun; 26(7):891-5. PubMed ID: 6929745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
    Metzgar RS; Mohanakumar T; Bolognesi DP
    J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two major tyrosine protein kinases of resting human T lymphocytes are down-regulated following mitotic stimulation.
    Hall BS; Hoffbrand AV; Wickremasinghe RG
    FEBS Lett; 1987 Oct; 223(1):6-10. PubMed ID: 3499351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of 5'-nucleotidase activity of human leukemic cells after fractionation: implications for cancer and aging.
    Sun AS; Renaud M
    Mutat Res; 1989; 219(5-6):295-302. PubMed ID: 2559327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
    Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
    J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine 5'-phosphate dehydrogenase activity in normal and leukemic blood cells.
    Becher HJ; Löhr GW
    Klin Wochenschr; 1979 Oct; 57(20):1109-15. PubMed ID: 292819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct beta-hexosaminidase isoenzyme separated from human leukemic lymphocytes and myelocytes.
    Orlacchio A; Maffei C; Emiliani C; Rambotti P; Davis S
    Biochem Biophys Res Commun; 1984 Aug; 122(3):966-73. PubMed ID: 6236812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human leukemic-cell protein-kinases. 1 - Non-granulocytic leukemias (author's transl)].
    Boivin P; Galand C
    Nouv Rev Fr Hematol (1978); 1981; 23(5):257-65. PubMed ID: 6276861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation of phospholipid-sensitive Ca2+-dependent protein kinase and its substrate, Mr 38,000 protein, in chronic myelocytic and acute myelocytic leukemias.
    Sakurada K; Miyazaki T; Kimura K; Yamabe M; Katabami F; Koyama M; Uehara Y; Katoh N
    Cancer Res; 1985 Feb; 45(2):903-8. PubMed ID: 3155648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.